Verdence Capital Advisors’s Geron GERN Stock Holding History

Verdence Capital Advisors’s Portfolio GERN Stock Details GERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-10,000	Closed	-$14K	–	510
2021 Q2	$14K	Buy	+10,000	New	+$14.5K	﹤0.01%	475

Other funds holding GERN

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Verdence Capital Advisors's GERN Position: Q3 2021 in Review

Verdence Capital Advisors sold out of Geron (GERN) in Q3 2021, closing a stake of 10,000 shares — an estimated $14K sold.

Verdence Capital Advisors first reported a position in GERN in Q2 2021 and held it in 1 quarter. The position peaked at $14K in Q2 2021. 139 funds tracked by Wall St. Rank hold GERN as of Q3 2021.

Verdence Capital Advisors reported no remaining Geron position as of Q3 2021 after selling out during the quarter.
Verdence Capital Advisors sold 10,000 Geron shares in Q3 2021, an estimated $14K.
Verdence Capital Advisors first reported a position in Geron in Q2 2021 and held it in 1 quarter.
Verdence Capital Advisors's Geron position peaked at $14K in Q2 2021.
139 funds tracked by Wall St. Rank held Geron as of Q3 2021.

Based on Verdence Capital Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.